Infant, Premature, Diseases, Pain, Respiratory Distress Syndrome, Stress, Surfactant Deficiency Syndrome Neonatal
Conditions
Keywords
Less-Invasive-Surfactant-Administration, Skin Conductance, Neonatal Pain and Sedation Scale, Analgosedation, General stress-level
Brief summary
Primary aims of the study are to evaluate the feasibility of Skin conductance (SC) measurements and its correlation to Neonatal Pain and Distress Scale (N-PASS) - scores during the Less-Invasive-Surfactant-Administration (LISA)-procedure in preterm infants. Secondary aims are to evaluate the effect of LISA on the general stress-level in preterm infants with respiratory distress syndrome. The assessment of pain and stress with SC measurement in addition to the subjective assessment with N-PASS may provide more conclusive data on the sensation of pain or stress during the LISA procedure and therefore the necessity of analgosedation. Therefore, this study might help to identify those infants in need for analgosedation, which would allow an individualized approach in the future.
Interventions
OTHERSkin Conductance (SC) Measurement
SC will be measured using a specific monitor and three self-adhesive electrodes on one foot of the infant (one plantar and two on the ankles). Peaks per second (the rate of firing in the sympathetic nerves), average amplitude (mean peaks) and area under curve (forcefulness of sympathetic nerve firing) will be automatically analyzed. Corresponding data will be transferred to a separate tablet computer via bluetooth.
OTHERVideo Recording
The video recording for later N-PASS assessment will be done by a camera fixed above the incubator / resuscitation unit, not interfering with the LISA procedure. The video will show the full body of the newborn as well as the hands / forearms of the treating clinical team with the awareness and oral consent of the treating team.
Sponsors
University of Zurich
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
No minimum to 48 Years
Healthy volunteers
No
Inclusion criteria
* Preterm infants ≥27 0/7 weeks of gestation at birth * Need for surfactant therapy via LISA according to the local standard operating procedure * ≥27 0/7 weeks of gestation, * within first 48 hours of life * FiO2 ≥0.30 to maintain SpO2 ≥90% for 15 min, * non-invasive respiratory support with PEEP 6-8 cmH2O * consent of attending NICU staff for videorecording
Exclusion criteria
* Primary intubation in the delivery room * Severe congenital malformation or other conditions requiring immediate endotracheal intubation * Insufficient language skills (German or English) of the parents to understand and consent the participation in the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Median peaks per second at prespecified time-points adjusted for median peaks per second at baseline | 2 minutes before LISA, during LISA, 1 hour (±10 minutes) after LISA | The prespecified time-points are: 1. baseline: before starting of interventions (2 minutes recording without any intervention); 2. insertion of nasopharyngeal tube; 3. insertion of laryngoscope for visualization of the vocal cords; 4. insertion of LISA catheter 5. administration of surfactant 6. removal of catheter 7. 5 minutes after removal of catheter (2 minutes recording without any intervention) 8. 1 hour (±10 minutes) after LISA (2 minutes recording without any intervention) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of intraventricular hemorrhage | 72 hours after LISA | Incidence of intraventricular hemorrhage at first ultrasound scan after 72 hours |
| Median Neonatal Pain, Agitation and Sedation Scale (N-PASS) at prespecified time-points, adjusted for median N-PASS at baseline | 2 minutes before LISA, during LISA, 1 hour (±10 minutes) after LISA | The N-PASS serves as a tool for evaluating pain and sedation levels in newborns. In the context of this study, the focus is solely on assessing pain. Five criteria, including crying, behavior, facial expression, extremity tone and vital signs, are rated on a scale of 0 to 2 points each. These individual scores are then added up to calculate a total pain score, which falls within the range of 0 to 10. A higher total score correlates with a higher level of perceived pain. The prespecified time-points, at which the N-PASS will be assessed, are: 1. baseline: before starting of interventions 2. during insertion of laryngoscope for visualization of the vocal cords 3. administration of surfactant 4. 5 minutes after removal of catheter 5. 1 hour (±10 minutes) after LISA |
| Absolute number of apneas | During LISA procedure | Absolute number of apneas requiring non-invasive pressure ventilation or increase of peak inspiratory pressure or frequency during the LISA procedure |
| Absolute number of desaturations | During LISA procedure | Absolute number of decreasing SpO2 requiring increase of FiO2 during the LISA procedure |
| Absolute number of bradycardia | During LISA procedure | Absolute number of bradycardia (\<100/min) during the LISA procedure |
| Absolute number of arterial hypotension | During LISA procedure | Absolute number of arterial hypotension with mean blood pressure lower than gestational age during the LISA procedure |
| Absolute number of blunt surfactant reflux | During LISA procedure | Absolute number of blunt surfactant reflux seen in mouth or nose without laryngoscopy during the LISA procedure |
| Difference in maximum peaks per second before and after apnea | During LISA procedure | Difference in maximum peaks per second before and after apnea requiring non-invasive pressure ventilation or increase of peak inspiratory pressure or frequency during the LISA procedure |
| Difference in median peaks per second during 20-second interval before and after apnea | During LISA procedure | Difference in median peaks per second during 20-second interval before and after apnea requiring non-invasive pressure ventilation or increase of peak inspiratory pressure or frequency during the LISA procedure |
| Difference in maximum peaks per second before and after desaturation | During LISA procedure | Difference in maximum peaks per second before and after decreasing SpO2 requiring increase of FiO2 during the LISA procedure |
| Difference in median peaks per second during 20-second interval before and after desaturation | During LISA procedure | Difference in median peaks per second during 20-second interval before and after decreasing SpO2 requiring increase of FiO2 during the LISA procedure |
| Difference in maximum peaks per second before and after bradycardia | During LISA procedure | Difference in maximum peaks per second before and after bradycardia (\<100/min) during the LISA procedure |
| Difference in median peaks per second during 20-second interval before and after bradycardia | During LISA procedure | Difference in median peaks per second during 20-second interval before and after bradycardia (\<100/min) during the LISA procedure |
| Difference in maximum peaks per second before and after arterial hypotension | During LISA procedure | Difference in maximum peaks per second before and after arterial hypotension with mean blood pressure lower than gestational age during the LISA procedure |
| Difference in median peaks per second during 20-second interval before and after arterial hypotension | During LISA procedure | Difference in median peaks per second during 20-second interval before and after arterial hypotension with mean blood pressure lower than gestational age during the LISA procedure |
| Difference in maximum peaks per second before and after blunt surfactant reflux | During LISA procedure | Difference in maximum peaks per second before and after blunt surfactant reflux seen in mouth or nose without laryngoscopy during the LISA procedure |
| Difference in median peaks per second during 20-second interval before and after blunt surfactant reflux | During LISA procedure | Difference in median peaks per second during 20-second interval before and after blunt surfactant reflux seen in mouth or nose without laryngoscopy during the LISA procedure |
| Difference in heart-rate between baseline and prespecified time-points as listed above. | 2 minutes before LISA, during LISA, 1 hour (±10 minutes) after LISA | Difference in heart-rate between baseline and prespecified time-points as listed above 2 minutes before LISA, during LISA and 1 hour (±10 minutes) after LISA |
| Difference in oxygen saturation between baseline and prespecified time-points as listed above. | 2 minutes before LISA, during LISA, 1 hour (±10 minutes) after LISA | Difference in oxygen saturation between baseline and prespecified time-points as listed above 2 minutes before LISA, during LISA and 1 hour (±10 minutes) after LISA |
| Difference in SpO2/FiO2-ratio between baseline and prespecified time-points as listed above. | 2 minutes before LISA, during LISA, 1 hour (±10 minutes) after LISA | Difference in SpO2/FiO2-ratio between baseline and prespecified time-points as listed above 2 minutes before LISA, during LISA and 1 hour (±10 minutes) after LISA |
| Difference of SpO2/FiO2-ratio compared to skin conductance peaks per second | 2 minutes before LISA, 5 minutes after removal of catheter, 60 Minutes after LISA | Difference of SpO2/FiO2-ratio at baseline, 5 minutes after removal of catheter and 60 minutes after LISA compared to skin conductance peaks per second (median peaks per second of 2 minute intervals). |
| LISA failure | Within 24 hours after LISA | Incidence of LISA failure defined as intubation or repeated LISA within 24 hours |
| Air-leaks <72 hours after the LISA procedure | Within 72 hours after LISA | Incidence of air-leaks within \<72 hours after the LISA procedure |
| Intubation <72 hours after the LISA procedure | Within 72 hours after LISA | Incidence of intubation within \<72 hours after the LISA procedure |
Countries
Switzerland
Contacts
STUDY_CHAIRDirk Bassler, MD
Newborn Research, Department of Neonatology, University Hospital and University of Zurich
Outcome results
None listed